miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8

Drug resistance remains a large obstacle for the treatment of ovarian cancer. miRNAs have been reported to be involved in cisplatin (CDDP) resistance in ovarian cancer. The aim of the present study was to investigate the function and mechanism of miR-199a-3p in the CDDP resistance in ovarian cancer....

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncol Rep
Päätekijät: Cui, Yajie, Wu, Fengqin, Tian, Defu, Wang, Ting, Lu, Tianjie, Huang, Xiying, Zhang, Peilian, Qin, Li
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: D.A. Spandidos 2018
Aiheet:
Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5868401/
https://ncbi.nlm.nih.gov/pubmed/29436681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2018.6259
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia